COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20210505051197N1


Column Value
Trial registration number IRCT20210505051197N1
Full text link
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Dr Mohammadreza Naghipour

Contact
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

research@gums.ac.ir

Registration date
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-07-18

Recruitment status
Last imported at : Feb. 18, 2022, 5:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RT-PCR test positive for SARS-CoV-2 criteria for patients with moderate symptoms:evidence of lower respiratory disease( dyspnea, Chest compression و..) oxygen saturation (SpO2) between 90 to 93% lung infiltrates<50% criteria for patients with sever symptoms: Dyspnea respiratory frequency >30 breaths/min oxygen saturation (SpO2) < 90% and PaO2/FiO2 <300 mm Hg lung infiltrates >50%

Exclusion criteria
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

patients with mild symptoms diabetes hypertension pregnant women those who have already been in clinical trial with other drugs. Age less than 18 years

Number of arms
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

3

Funding
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Rasht University of Medical Sciences

Inclusion age min
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Moderate/severe disease at enrollment

Severity scale
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

96

primary outcome
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

C-Reactive Protein serum levels erythrocyte sedimentation rate serum levels

Notes
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 2/Phase 3

Arms
Last imported at : July 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "6 mg", "treatment_id": 779, "treatment_name": "Melatonin", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "12 mg", "treatment_id": 779, "treatment_name": "Melatonin", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]